The relative proportion of IgM-positive patients decreased over time; in fact, 40% of COVID-19-positive patients who were tested within the first 21 days after biomolecular testing showed IgM positivity, while this proportion fell to 25% in later tested patients. The gene discussed is CD40LG; the disease is COVID-19.